Under the agreement, Smith & Nephew will hold distribution rights for Graftys’ fast-setting, macroporous calcium phosphate bone void filler in the United States with the potential for additional countries around the world.
Graftys produces an injectable, hard-setting resorbable calcium phosphate bone substitute which provides a support scaffold for bone growth. It can also be mixed and applied in situ.
Read the release about the partnership between Graftys and Smith & Nephew.
Related Articles on Smith & Nephew:
Smith & Nephew Introduces Short Modular Femoral Hip System
Smith & Nephew Introduce TWINFIX Suture Anchor for Rotator Cuff Repair
Smith & Nephew, Nanotope Partner in Cartilage Regeneration Project
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
